Esophagus Cancer, Stage III
3 clinical trials · Condition
◉ Watch Esophagus Cancer, Stage III
| Record | Firm | Date |
|---|---|---|
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| GASC1 Inhibitor Caffeic Acid for Squamous Esophageal Cell Cancer (ESCC) (NCT04648917) | The First Affiliated Hospital of Henan University of Science and Technology | 2019-05-01 |
| An Exploratory Clinical Study of Apatinib for the 2nd Treatment of Esophageal Cancer or Esophageal and Gastric (NCT03285906) | Tianjin Medical University Cancer Institute and Hospital | 2017-03-01 |
Track Esophagus Cancer, Stage III automatically
Every clearance here is in the API, with alerts when new ones post.